EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults

Zhu Luo, Jie Wang iD, Zhuolu Niu, Cuili Hu iD, Madhu Chintala, Xinchao Luo, Tsung-I Lee, Alexei N Plotnikov, Peter Zannikos iD

Drug Design, Development and Therapy · 2025-03 · Volume 19 · 1503-1514

DOI: 10.2147/dddt.s488414 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025-03. Verfasst von Zhu Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China. Hauptthemen laut MEDLINE: Anticoagulants. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsAdultFemaleHumansMaleMiddle AgedYoung AdultAdministration, OralArea Under CurveChinaDose-Response Relationship, DrugHealthy VolunteersPartial Thromboplastin TimePyrimidinesTriazolesEast Asian People

Stichwörter der Autor:innen

FXIa inhibitoraPTTanticoagulantmilvexianpharmacokinetics

Substanzen

AnticoagulantsmilvexianPyrimidinesTriazoles

Autor:innen und Institutionen

  • Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • Department of Hematology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • Johnson & Johnson, Shanghai, People's Republic of China.
  • Johnson & Johnson, Beijing, People's Republic of China.
  • Johnson & Johnson, Raritan, NJ, USA.

ORCID-Profile: Jie Wang, Cuili Hu, Peter Zannikos

Zitieren

APA

Luo, Z., Wang, J., Niu, Z., Hu, C., Chintala, M., Luo, X., Lee, T. I., Plotnikov, A. N., & Zannikos, P. (2025). Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults. Drug Design, Development and Therapy, Volume 19, 1503-1514. https://doi.org/10.2147/dddt.s488414

Vancouver

Luo Z, Wang J, Niu Z, Hu C, Chintala M, Luo X, et al. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults. Drug Design, Development and Therapy. 2025;Volume 19:1503-1514. doi:10.2147/dddt.s488414

BibTeX
@article{Luo2025,
  author = {Luo, Zhu and Wang, Jie and Niu, Zhuolu and Hu, Cuili and Chintala, Madhu and Luo, Xinchao and Lee, Tsung-I and Plotnikov, Alexei N and Zannikos, Peter},
  title = {Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {1503--1514},
  doi = {10.2147/dddt.s488414}
}
Kostenlos starten →